The global Urokinase market size was valued at US$ 51.2 million in 2024 and is forecast to a readjusted size of USD 72.2 million by 2031 with a CAGR of 5.1% during review period.
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Global key players of urokinase include Syner-Med, LIVZON, Wanhua Biochem, etc. The top three players hold a share about 50%. China is the largest market of Urokinase, holding a share about 56%, followed by Europe and North America.
This report is a detailed and comprehensive analysis for global Urokinase market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Urokinase market size and forecasts, in consumption value ($ Million), sales quantity (BIU), and average selling prices (US$/MIU), 2020-2031
Global Urokinase market size and forecasts by region and country, in consumption value ($ Million), sales quantity (BIU), and average selling prices (US$/MIU), 2020-2031
Global Urokinase market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (BIU), and average selling prices (US$/MIU), 2020-2031
Global Urokinase market shares of main players, shipments in revenue ($ Million), sales quantity (BIU), and ASP (US$/MIU), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Urokinase
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Urokinase market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Syner-Med, Wanhua Biochem, Jiangxi Haoran Bio-Pharma, Jiangsu Aidea Pharmaceutical, Techpool, Microbic Biosystems, LIVZON, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Urokinase market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Urokinase Powder
Urokinase Solution
麻豆原创 segment by Application
Hospital
Clinic
Others
Major players covered
Syner-Med
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems
LIVZON
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Urokinase product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Urokinase, with price, sales quantity, revenue, and global market share of Urokinase from 2020 to 2025.
Chapter 3, the Urokinase competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Urokinase breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Urokinase market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Urokinase.
Chapter 14 and 15, to describe Urokinase sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Urokinase Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Urokinase Powder
1.3.3 Urokinase Solution
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Urokinase Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Urokinase 麻豆原创 Size & Forecast
1.5.1 Global Urokinase Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Urokinase Sales Quantity (2020-2031)
1.5.3 Global Urokinase Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Syner-Med
2.1.1 Syner-Med Details
2.1.2 Syner-Med Major Business
2.1.3 Syner-Med Urokinase Product and Services
2.1.4 Syner-Med Urokinase Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Syner-Med Recent Developments/Updates
2.2 Wanhua Biochem
2.2.1 Wanhua Biochem Details
2.2.2 Wanhua Biochem Major Business
2.2.3 Wanhua Biochem Urokinase Product and Services
2.2.4 Wanhua Biochem Urokinase Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Wanhua Biochem Recent Developments/Updates
2.3 Jiangxi Haoran Bio-Pharma
2.3.1 Jiangxi Haoran Bio-Pharma Details
2.3.2 Jiangxi Haoran Bio-Pharma Major Business
2.3.3 Jiangxi Haoran Bio-Pharma Urokinase Product and Services
2.3.4 Jiangxi Haoran Bio-Pharma Urokinase Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Jiangxi Haoran Bio-Pharma Recent Developments/Updates
2.4 Jiangsu Aidea Pharmaceutical
2.4.1 Jiangsu Aidea Pharmaceutical Details
2.4.2 Jiangsu Aidea Pharmaceutical Major Business
2.4.3 Jiangsu Aidea Pharmaceutical Urokinase Product and Services
2.4.4 Jiangsu Aidea Pharmaceutical Urokinase Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Jiangsu Aidea Pharmaceutical Recent Developments/Updates
2.5 Techpool
2.5.1 Techpool Details
2.5.2 Techpool Major Business
2.5.3 Techpool Urokinase Product and Services
2.5.4 Techpool Urokinase Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Techpool Recent Developments/Updates
2.6 Microbic Biosystems
2.6.1 Microbic Biosystems Details
2.6.2 Microbic Biosystems Major Business
2.6.3 Microbic Biosystems Urokinase Product and Services
2.6.4 Microbic Biosystems Urokinase Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Microbic Biosystems Recent Developments/Updates
2.7 LIVZON
2.7.1 LIVZON Details
2.7.2 LIVZON Major Business
2.7.3 LIVZON Urokinase Product and Services
2.7.4 LIVZON Urokinase Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 LIVZON Recent Developments/Updates
3 Competitive Environment: Urokinase by Manufacturer
3.1 Global Urokinase Sales Quantity by Manufacturer (2020-2025)
3.2 Global Urokinase Revenue by Manufacturer (2020-2025)
3.3 Global Urokinase Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Urokinase by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Urokinase Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Urokinase Manufacturer 麻豆原创 Share in 2024
3.5 Urokinase 麻豆原创: Overall Company Footprint Analysis
3.5.1 Urokinase 麻豆原创: Region Footprint
3.5.2 Urokinase 麻豆原创: Company Product Type Footprint
3.5.3 Urokinase 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Urokinase 麻豆原创 Size by Region
4.1.1 Global Urokinase Sales Quantity by Region (2020-2031)
4.1.2 Global Urokinase Consumption Value by Region (2020-2031)
4.1.3 Global Urokinase Average Price by Region (2020-2031)
4.2 North America Urokinase Consumption Value (2020-2031)
4.3 Europe Urokinase Consumption Value (2020-2031)
4.4 Asia-Pacific Urokinase Consumption Value (2020-2031)
4.5 South America Urokinase Consumption Value (2020-2031)
4.6 Middle East & Africa Urokinase Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Urokinase Sales Quantity by Type (2020-2031)
5.2 Global Urokinase Consumption Value by Type (2020-2031)
5.3 Global Urokinase Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Urokinase Sales Quantity by Application (2020-2031)
6.2 Global Urokinase Consumption Value by Application (2020-2031)
6.3 Global Urokinase Average Price by Application (2020-2031)
7 North America
7.1 North America Urokinase Sales Quantity by Type (2020-2031)
7.2 North America Urokinase Sales Quantity by Application (2020-2031)
7.3 North America Urokinase 麻豆原创 Size by Country
7.3.1 North America Urokinase Sales Quantity by Country (2020-2031)
7.3.2 North America Urokinase Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Urokinase Sales Quantity by Type (2020-2031)
8.2 Europe Urokinase Sales Quantity by Application (2020-2031)
8.3 Europe Urokinase 麻豆原创 Size by Country
8.3.1 Europe Urokinase Sales Quantity by Country (2020-2031)
8.3.2 Europe Urokinase Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Urokinase Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Urokinase Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Urokinase 麻豆原创 Size by Region
9.3.1 Asia-Pacific Urokinase Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Urokinase Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Urokinase Sales Quantity by Type (2020-2031)
10.2 South America Urokinase Sales Quantity by Application (2020-2031)
10.3 South America Urokinase 麻豆原创 Size by Country
10.3.1 South America Urokinase Sales Quantity by Country (2020-2031)
10.3.2 South America Urokinase Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Urokinase Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Urokinase Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Urokinase 麻豆原创 Size by Country
11.3.1 Middle East & Africa Urokinase Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Urokinase Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Urokinase 麻豆原创 Drivers
12.2 Urokinase 麻豆原创 Restraints
12.3 Urokinase Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Urokinase and Key Manufacturers
13.2 Manufacturing Costs Percentage of Urokinase
13.3 Urokinase Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Urokinase Typical Distributors
14.3 Urokinase Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Syner-Med
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems
LIVZON
听
听
*If Applicable.
